Alastair Stewart is a Professor of Pharmacology, Co-Director of the Lung Health Research Centre Director of the ARC Industrial Transformation Centre for Personalised Therapeutic Technologies at the University of Melbourne and Chief Scientific Officer of TianLi Biotech, a newly formed company developing anti-inflammatory and anti-fibrotic drugs. His research interests focus on tissue remodelling and a quest for discovery and development of novel drugs targeting tissue remodelling and inflammation. He is developing and applying the concept of Mechanopharmacology in drug discovery and ultra-high content, sub-acute disease modelling, drug screening and lead qualification. He is currently Vice President of the Asia Pacific Federation of Pharmacologists. He promotes interdisciplinary research through leadership roles on Editorial Boards including Frontiers in Translational Pharmacology, Current Opinion in Pharmacology and the American Society of Mechanical Engineering Journal of Engineering and Science in Medical Diagnostics and Therapy.